Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
SEC Won't Comment on Speculation of Valeant Pharmaceuticals (VRX) Probe
October 22, 2015 3:43 PM EDTThe SEC would not comment to StreetInsider.com on speculation that it is investigating Valeant Pharmaceuticals (NYSE: VRX) amid allegations related to its relationship with Philidor and R&O, accounting practices, and channel stuffing. "As per our policy, we can not confirm or... More
Valeant Pharma (VRX) to Hold Investor Conference Call on October 26
October 22, 2015 2:39 PM EDTValeant Pharma (NYSE: VRX) today announced that it will host a conference call and a live webcast along with a slide presentation on Monday, October 26, 2015 at 8:00 a.m. ET (5:00 a.m. PT). The purpose of the call will be to lay out the facts including allegations made against our company regarding our relationship with Philidor and R&O, our accounting practices, and channel stuffing that contain numerous errors, unsupported speculation and incorrect... More
Valeant Pharma (VRX) Will Hold Investor Conf. Call on Oct. 26th
October 22, 2015 2:39 PM EDTValeant Pharma (NYSE: VRX) announced that it will host a conference call and a live webcast along with a slide presentation on Monday, October 26, 2015 at 8:00 a.m. ET (5:00 a.m. PT). The purpose of the call will be to lay out the facts including allegations made against our company regarding our relationship with Philidor and R&O, our accounting practices, and channel stuffing that contain numerous errors, unsupported speculation and incorrect interpretations of... More
